Figure 1.
Schematic illustration of the design of the experiment, performed to determine whether the repetitive administration of CoPP (5 mg/kg) or GYY4137 (35 mg/kg) intraperitoneally injected over 5 and 4 consecutive days, respectively, can reverse the nociceptive responses caused by PTX and the associated emotional disorders. PTX: paclitaxel.